Conference on personalised cancer therapy

Barcelona: 3-4 December 2012

The organisers of the IDIBELL Cancer Conference (ICC) on Personalized Cancer Medicine – Manel Esteller, George Thomas, Cristina Muñoz- Pinedo and Sara Kozma – will present 21speakers for the event, all leading oncologists and cancer researchers, particularly those working in the study of genetic and epigenetic defects leading to the selection of cancer patients for new drug therapies. The meeting aims to highlight the latest understanding of biological mechanisms and natural history of cancer, thus providing novel targets for therapy, as well as to discuss the molecular mechanisms involved in the stratification of oncology patents according to the recently described molecular markers. Special focus: Epigenetics and DNA Repair and the metabolism and cell signalling areas with the updated clinical applications. Details: http://bocemtium.com

05.11.2012

More on the subject:

Related articles

Photo

News • Mutational process analysis

Scientists explore DNA damage in prostate cancer for better predictions

New research offers an explanation for why many men live with prostate cancer for decades while for others it turns lethal: The work identifies which processes cause DNA damage in most of the cancers.

Photo

News • Immunotherapy first, surgery afterwards

Glioblastoma: treatment sequence matters

In glioblastoma, the treatment order matters: a new study shows that administering cell immunotherapy before surgery to remove a brain tumour is significantly more effective than the other way around.

Photo

News • Interventional oncology

AI segmentation and robotic guidance showcased at CIRSE 2026

At CIRSE 2026, Precision IO presents Smart Seg AI for liver tumour segmentation and a new integration with GE HealthCare's Allia Moveo system for its Epione platform.

Subscribe to Newsletter